ENVIRONMENTAL AND MOLECULAR MUTAGENESIS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1090109, encodeId=72b310901098f, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090110, encodeId=ea9e109011057, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590826, encodeId=d2125908261e, content=投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表: 请问后来投哪里呀？, beContent=189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe205323712, createdName=148b3f45m08暂无昵称, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574666, encodeId=70cf5e4666c0, content=请问后来投哪里呀？da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表: 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=926a2491965, createdName=1247e2a7m59(暂无昵称), createdTime=Sun Aug 11 00:00:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544998, encodeId=f80b54499857, content=审稿速度:2.0 经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue Aug 01 16:01:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536760, encodeId=b766536e608f, content=这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue May 16 10:50:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506225, encodeId=7f0f5062259e, content=2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。 我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:38:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481283, encodeId=9b29481283e1, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476983, encodeId=3e7c4e698317, content=偏重的研究方向：环境科学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0928243, createdName=iou0515, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

摘要需要详细到什么程度？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1090109, encodeId=72b310901098f, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090110, encodeId=ea9e109011057, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590826, encodeId=d2125908261e, content=投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表: 请问后来投哪里呀？, beContent=189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe205323712, createdName=148b3f45m08暂无昵称, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574666, encodeId=70cf5e4666c0, content=请问后来投哪里呀？da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表: 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=926a2491965, createdName=1247e2a7m59(暂无昵称), createdTime=Sun Aug 11 00:00:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544998, encodeId=f80b54499857, content=审稿速度:2.0 经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue Aug 01 16:01:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536760, encodeId=b766536e608f, content=这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue May 16 10:50:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506225, encodeId=7f0f5062259e, content=2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。 我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:38:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481283, encodeId=9b29481283e1, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476983, encodeId=3e7c4e698317, content=偏重的研究方向：环境科学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0928243, createdName=iou0515, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

摘要一般控制在多少字符以内？

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1090109, encodeId=72b310901098f, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090110, encodeId=ea9e109011057, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590826, encodeId=d2125908261e, content=投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表: 请问后来投哪里呀？, beContent=189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe205323712, createdName=148b3f45m08暂无昵称, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574666, encodeId=70cf5e4666c0, content=请问后来投哪里呀？da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表: 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=926a2491965, createdName=1247e2a7m59(暂无昵称), createdTime=Sun Aug 11 00:00:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544998, encodeId=f80b54499857, content=审稿速度:2.0 经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue Aug 01 16:01:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536760, encodeId=b766536e608f, content=这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue May 16 10:50:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506225, encodeId=7f0f5062259e, content=2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。 我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:38:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481283, encodeId=9b29481283e1, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476983, encodeId=3e7c4e698317, content=偏重的研究方向：环境科学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0928243, createdName=iou0515, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2020-05-14 148b3f45m08暂无昵称

投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表::
请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表:
请问后来投哪里呀？

189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？

114 0

[GetPortalCommentsPageByObjectIdResponse(id=1090109, encodeId=72b310901098f, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090110, encodeId=ea9e109011057, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590826, encodeId=d2125908261e, content=投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表: 请问后来投哪里呀？, beContent=189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe205323712, createdName=148b3f45m08暂无昵称, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574666, encodeId=70cf5e4666c0, content=请问后来投哪里呀？da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表: 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=926a2491965, createdName=1247e2a7m59(暂无昵称), createdTime=Sun Aug 11 00:00:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544998, encodeId=f80b54499857, content=审稿速度:2.0 经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue Aug 01 16:01:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536760, encodeId=b766536e608f, content=这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue May 16 10:50:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506225, encodeId=7f0f5062259e, content=2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。 我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:38:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481283, encodeId=9b29481283e1, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476983, encodeId=3e7c4e698317, content=偏重的研究方向：环境科学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0928243, createdName=iou0515, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2019-08-11 1247e2a7m59(暂无昵称)

请问后来投哪里呀？da-xiang 2017-08-01 发表::
审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表:
经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~

da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~

146 0

[GetPortalCommentsPageByObjectIdResponse(id=1090109, encodeId=72b310901098f, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090110, encodeId=ea9e109011057, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590826, encodeId=d2125908261e, content=投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表: 请问后来投哪里呀？, beContent=189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe205323712, createdName=148b3f45m08暂无昵称, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574666, encodeId=70cf5e4666c0, content=请问后来投哪里呀？da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表: 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=926a2491965, createdName=1247e2a7m59(暂无昵称), createdTime=Sun Aug 11 00:00:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544998, encodeId=f80b54499857, content=审稿速度:2.0 经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue Aug 01 16:01:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536760, encodeId=b766536e608f, content=这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue May 16 10:50:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506225, encodeId=7f0f5062259e, content=2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。 我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:38:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481283, encodeId=9b29481283e1, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476983, encodeId=3e7c4e698317, content=偏重的研究方向：环境科学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0928243, createdName=iou0515, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2017-08-01 da-xiang

审稿速度:2.0
经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~

318 0

[GetPortalCommentsPageByObjectIdResponse(id=1090109, encodeId=72b310901098f, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090110, encodeId=ea9e109011057, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590826, encodeId=d2125908261e, content=投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表: 请问后来投哪里呀？, beContent=189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe205323712, createdName=148b3f45m08暂无昵称, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574666, encodeId=70cf5e4666c0, content=请问后来投哪里呀？da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表: 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=926a2491965, createdName=1247e2a7m59(暂无昵称), createdTime=Sun Aug 11 00:00:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544998, encodeId=f80b54499857, content=审稿速度:2.0 经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue Aug 01 16:01:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536760, encodeId=b766536e608f, content=这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue May 16 10:50:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506225, encodeId=7f0f5062259e, content=2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。 我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:38:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481283, encodeId=9b29481283e1, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476983, encodeId=3e7c4e698317, content=偏重的研究方向：环境科学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0928243, createdName=iou0515, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2017-05-16 da-xiang

这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！

376 0

[GetPortalCommentsPageByObjectIdResponse(id=1090109, encodeId=72b310901098f, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090110, encodeId=ea9e109011057, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590826, encodeId=d2125908261e, content=投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表: 请问后来投哪里呀？, beContent=189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe205323712, createdName=148b3f45m08暂无昵称, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574666, encodeId=70cf5e4666c0, content=请问后来投哪里呀？da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表: 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=926a2491965, createdName=1247e2a7m59(暂无昵称), createdTime=Sun Aug 11 00:00:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544998, encodeId=f80b54499857, content=审稿速度:2.0 经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue Aug 01 16:01:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536760, encodeId=b766536e608f, content=这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue May 16 10:50:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506225, encodeId=7f0f5062259e, content=2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。 我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:38:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481283, encodeId=9b29481283e1, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476983, encodeId=3e7c4e698317, content=偏重的研究方向：环境科学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0928243, createdName=iou0515, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2014-09-23 刘云岗

2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。
我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。

336 0

[GetPortalCommentsPageByObjectIdResponse(id=1090109, encodeId=72b310901098f, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090110, encodeId=ea9e109011057, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590826, encodeId=d2125908261e, content=投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表: 请问后来投哪里呀？, beContent=189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe205323712, createdName=148b3f45m08暂无昵称, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574666, encodeId=70cf5e4666c0, content=请问后来投哪里呀？da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表: 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=926a2491965, createdName=1247e2a7m59(暂无昵称), createdTime=Sun Aug 11 00:00:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544998, encodeId=f80b54499857, content=审稿速度:2.0 经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue Aug 01 16:01:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536760, encodeId=b766536e608f, content=这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue May 16 10:50:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506225, encodeId=7f0f5062259e, content=2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。 我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:38:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481283, encodeId=9b29481283e1, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476983, encodeId=3e7c4e698317, content=偏重的研究方向：环境科学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0928243, createdName=iou0515, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2011-06-29 medwu

看涨哦，如果明天再升一升，有望突破3分

439 0

[GetPortalCommentsPageByObjectIdResponse(id=1090109, encodeId=72b310901098f, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090110, encodeId=ea9e109011057, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590826, encodeId=d2125908261e, content=投去了mutation research 189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？189EV8b5259(暂无昵称) 2019-08-11 00:00:00 发表: 请问后来投哪里呀？, beContent=189EV8b5259(暂无昵称) 2019-08-11 发表:: 请问后来投哪里呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe205323712, createdName=148b3f45m08暂无昵称, createdTime=Thu May 14 00:00:00 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574666, encodeId=70cf5e4666c0, content=请问后来投哪里呀？da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~da-xiang 2017-08-01 16:01:00 发表: 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=da-xiang 2017-08-01 发表:: 审稿时间：约2个月 SCI(2016)：3.575 经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=926a2491965, createdName=1247e2a7m59(暂无昵称), createdTime=Sun Aug 11 00:00:00 CST 2019, time=2019-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544998, encodeId=f80b54499857, content=审稿速度:2.0 经验分享：经过2个月的一审，结果被拒。但是审稿人给了很多建设性的意见！再接再厉吧~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=318, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue Aug 01 16:01:00 CST 2017, time=2017-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=536760, encodeId=b766536e608f, content=这个杂志杂志怎么这么久没有战友分享经验了，最近投了一篇，under review中，期盼好运！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/05/14/2898b376c776c22ab6af859e66faa209.jpg, createdBy=78131975014, createdName=da-xiang, createdTime=Tue May 16 10:50:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506225, encodeId=7f0f5062259e, content=2014年3月初投稿，审稿不到1月就得到一审意见：拒稿，理由比较有说服力，部分也是投稿时心里有数的弱点。 我们按审稿意见重新作试验，花时间3个月。7月17日重新投稿到该期刊。8月14日得一审意见：Minor revision。问题都不难，8月19日我们提交修改稿；8月29日主编来信说责编在25日就建议接受，但主编读后觉得文章语言风格不太贴切该期刊，因此他委托一个Editing Service作了语言上的一点加工（但没有收费），发回我确认，并提出两点他觉得有疑问的地方。我们原则上接受了语言的加工，对加工中意思走样的个别地方也提出了纠正，并处理了主编的两个疑问。9月5日我们提交修改稿，9月8日主编宣布接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=刘云岗, createdTime=Tue Sep 23 09:38:00 CST 2014, time=2014-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481283, encodeId=9b29481283e1, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476983, encodeId=3e7c4e698317, content=偏重的研究方向：环境科学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa0928243, createdName=iou0515, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2011-06-28 iou0515

偏重的研究方向：环境科学;

526 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务